Company: CLX
Filing Date: 2025-10-07
Form Type: DEF 14A
Source: 0001552781-25-000311
Chunk: 0

Company: CLOROX CO /DE/
Filing Date: 2025-10-07
Form: DEF 14A
Chunk 0
---
 We also scaled new systems and capabilities to drive 
 savings across our portfolio, enabling reinvestment in strategic growth initiatives.      |

| • | Innovate                                                                                              
 Experiences: This                                                                                     
 year we launched innovations across all major brands, supported by an artificial intelligence-enabled 
 digital core that accelerated our innovation cycle time and turned insights into superior             
 experiences across different consumer needs. We bolstered our brands with advertising                 
 that reinforced trust and relevance, all while leveraging our personalization strategy                
 to achieve strong returns on our advertising investment.                                              |

| • | Reimagine                                                                             
 Work: With                                                                            
 our digital transformation and operating model acting as catalysts for more efficient 
 and consumer-centered ways of working, we continued to build the skills and culture   
 that empower our teams to move faster, adapt more effectively, and succeed together.  |

| • | Evolve                                                                                                                              
 the Portfolio: We are taking action                                                                                                 
 to strengthen our core and respond to consumer trends to ensure enduring brand relevance. This past fiscal year’s strategic actions 
 — including the completed divestiture of the Better Health Vitamins, Minerals and Supplements business — position us for            
 more consistent, profitable growth and a higher structural growth rate.                                                             |

Strengthening Board Oversight As the Company continues to transform to meet market and consumer demands, we have continued to evolve the Board to ensure it has the right mix of skills, experience, and perspectives to effectively oversee our corporate strategy. Over the past three years, we have welcomed five new directors, whose expertise enhances our Board’s effectiveness and reflects our commitment to thoughtful refreshment aligned with our strategy and values. I encourage you to read more about our other director nominees in this proxy statement – in addition to our business and sustainability progress in our fiscal year 2025 annual report. Fueled by our IGNITE strategy and guided by our values, I believe we are taking the right steps to position Clorox for the future — advancing to be more consumer-obsessed, faster, and leaner. Our fiscal year 2026 plan sets a strong foundation for new, scalable innovation platforms as we reinvigorate category growth and drive solid margin and earnings performance. Through it all, we are transforming Clorox to deliver more consistent, profitable growth and enhance long-term shareholder value. Thank you for your continued support. Linda Rendle

| The                                                                             
 Clorox Company 2025 Proxy Statement > Letter from Our Lead Independent Director | 2 |

| Letter                    
 from Our                  
 Lead Independent Director |

Dear